Binding kinetics of 11C-N-methyl piperidyl benzilate ( 11C-NMPB) in a rhesus monkey brain using the cerebellum as a reference region

Annals of Nuclear Medicine

Volumn 19, Issue 6, 2005, Pages 499-505

  Itoh, Takashi ^a   Tanaka, Masayasu ^b   Kobayashi, Kaoru ^c   Suzuki, Kazutoshi ^b   Inoue, Osamu ^c  

^a NIPPON MEDICAL SCHOOL   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Cerebellum; Conscious; Reference region; Rhesus monkey

Indexed keywords

CARBON 11; KETAMINE; MEPENZOLATE; METHYL IODIDE; MUSCARINIC RECEPTOR; BENZILIC ACID DERIVATIVE; DIAGNOSTIC AGENT; ENPIPERATE; PIPERIDINE DERIVATIVE; RADIOPHARMACEUTICAL AGENT;

ANESTHESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BRAIN CORTEX; CEREBELLUM; COMPETITIVE INHIBITION; CONSCIOUSNESS; CONTROLLED STUDY; CORPUS STRIATUM; DEMENTIA; DEVICE; HIPPOCAMPUS; MALE; MEMORY; MOTOR PERFORMANCE; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RECEPTOR DENSITY; REPRODUCIBILITY; RHESUS MONKEY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP; STATISTICAL ANALYSIS; THERMOREGULATION; ANIMAL; BINDING SITE; BRAIN; BRAIN MAPPING; EVALUATION; MACACA; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; PROTEIN BINDING; REFERENCE VALUE; SCINTISCANNING; STANDARD; TISSUE DISTRIBUTION;

ANIMALS; BENZILATES; BINDING SITES; BRAIN; BRAIN MAPPING; CEREBELLUM; MACACA MULATTA; MALE; METABOLIC CLEARANCE RATE; PIPERIDINES; POSITRON-EMISSION TOMOGRAPHY; PROTEIN BINDING; RADIOPHARMACEUTICALS; RECEPTORS, MUSCARINIC; REFERENCE VALUES; TISSUE DISTRIBUTION;

EID: 27444433535     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02985578     Document Type: Article

References (26)

1. Mitsui T. Acetylcholine receptor knockout mice. Nihon Shinkei Seishin Yakurigaku Zasshi 1999; 19: 233-238.
2. Bellingham MC, Ireland MF. Contribution of cholinergic systems to state-dependent modulation of respiratory control. Respir Physiol Neurobiol 2002; 131: 135-144.
3. Bartus RT, Dean RL 3rd, Beer B, Lippa AS. The cholinergic hypothesis of geriatric memory dysfunction. Science 1982; 217: 408-414.
4. Svensson AL, Alafuzoff I, Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Res 1992; 596: 142-148.
5. Hammer R, Berrie CP, Birdsall NJ, Burgen AS, Hulme EC. Pirenzepine distinguishes between different subclasses of muscarinei receptors. Nature 1980; 283: 90-92.
6. 3 receptors. J Phamacol Exp Ther 1987; 242: 257-262.
7. 3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. II. Characterization and regulation of antagonist binding to putative muscarinic subtypes. J Phamacol Exp Ther 1986; 237: 419-427.
8. 3H]zuinuclidinylbenzilate binding to muscarinic cholinergic receptor in rat brain. J Pharmacol Exp Ther 1984; 228: 648-655.
9. 125I]4IQNB is reflected in the in vivo washout of the radioligand from rat brain. Life Sci 1992; 50: 629-637.
10. Klood Y, Egozi Y, Sokolovsky M. Characterization of muscarinic acetylcholine receptors from mouse brain: evidence for regional heterogeneity and isomerizaion. Mol Pharmacol 1979; 15: 545-558.
11. Klood Y, Egozi Y, Sokolovsky M. Regional heterogeneity of muscarinic receptors of mouse brain. FEBS Lett 1979; 97: 265-268.
12. 3H-QNB in mouse brain. J Neural Transm 1999; 206: 583-592.
13. Suhara T, Inoue O, Kobayashi K, Suzuki K, Tateno Y. Age related changes in human muscarinic acetylcholine receptors measured by positron emission tomography. Neurosci Lett 1993; 149: 225-228.
14. 11C]NMPB and positron emission tomography: method development and differentiation of tracer delivery from receptor binding. J Cereb Blood Flow Metab 1998; 18: 619-631.
15. 11C]Ro15-1788 (flumazenil) in baboon and human during positron emission tomography studies. Eur J Drug Metab Pharmacokinet 1991; 16: 141-152.
16. 2 dopamine receptors in drug-naïve schizophrenics. Science 1986; 234: 1558-1563.
17. Millet P, Graf C, Buck A, Walder B, Ibanez V. Evaluation of the reference tissue models for PET and SPECT benzodiazepine binding parameters. Neuroimage 2002; 17: 928-942.
18. Estevez EE, Jerusalinsky D, Medina JH, De Robertis E. Cholinergic muscarinic receptors in rat cerebral cortex, basal ganglia and cerebellum undergo rapid and reversible changes after acute stress. Neuroscience 1984; 13: 1353-1357.
19. Miyoshi R, Kito S, Shimoyama M, Quantitative autoradiographic localization of Mi and MI subtypes of muscarinic acetylcholine receptors in monkey brain. Jpn J Pharmacol 1989; 51: 247-255.
20. Takechi H, Onoe H, Imamura K, Onoe K, Kakiuchi T, Nishiyama S, et al. Brain activation study by use of positron emission tomography in unanesthetized monkeys. Neurosci Lett 1994; 182: 279-282.
21. 11C]methylspiperone with high specific activity and high radiochemical puriety for PET studies: suppression of its radiolysis. Int J Rad Appl Instrum [A] 1990; 41: 593-599.
22. Patlak CS, Blasberg RG, Fenstermacher JD. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J Cereb Blood Flow Metab 1983; 3: 1-7.
23. 11C]4-MPB. Synapse 2001; 39 (2): 182-192.
24. 11C]methyl-3-piperidyl benzilate in the brains of conscious monkeys. Synapse 2001; 41: 248-257.
25. 11C-raclopride against anesthetics in rhesus monkey brain. L Neural Transm Gen Sect 1995; 100: 147-151.
26. Burdett NG, Menon DK, Chapenter TA, Jones JG, Hall LD. Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient echo sequences: preliminary results. Magn Reson Imaging 1995; 13: 549-553.